Scientists report setbacks in quest for AIDS cure

July 24, 2018
Credit: CC0 Public Domain

Scientists reported setbacks Tuesday in the quest for an AIDS cure, and highlighted concerns about inconclusive evidence linking a promising new HIV drug to birth defects.

According to research presented at the 22nd International AIDS Conference in Amsterdam, four cases of "neural tube" defects were recorded among the pregnancies of 426 HIV-positive women in Botswana who took the drug dolutegravir before conception.

Neural tube defects cause severe brain and spinal deformities in the first weeks after conception, and often lead to stillbirth.

The cases amount to a ratio of nearly one defect per 100 pregnancies, compared to the rate in the general population of about one per 1,000, researcher Rebecca Zash of the Harvard TH Chan School of Public Health explained.

The defects were observed between August 2014 and May this year.

There have been no new reports among 170 dolutegravir pregnancies monitored since, but Zash said, "I don't think we can take much reassurance" from that.

Four birth defects in 596 pregnancies was "still seven times higher than other groups, and statistically significant", she added.

Dolutegravir is a relatively new HIV-suppressor with fewer side-effects, and is thought less likely to spark drug resistance in patients.

Countries targeted by the US PEPFAR AIDS relief fund were on the cusp of rolling it out as the leading antiretroviral therapy (ART), International AIDS Society president Linda-Gail Bekker told AFP.

Waiting game

Botswana was the first country to introduce dolutegravir as a first-line antiretroviral drug for all who need it, including women of child-bearing age.

"This puts a very definite bump in the road," Bekker said, adding that conference organisers "scurried" to organise last-minute sessions to discuss the consequences of the Botswana results.

Pending clarification, global health agencies have advised HIV-positive women planning a family to use other antiretrovirals instead.

"I wish so badly that this (data) signal would go away" with further research, Zash told AFP.

In the meantime, "it's tough, but I think we just have to wait" for more information.

On the cure front, there was bad news too.

A trial to test a new strategy to "kick" the AIDS-causing HIV virus out of its hiding place in human cells, then "kill" it, yielded a disappointing outcome.

Researchers tested the effects of several medicines on top of standard ART in a trial with 60 HIV-positive men.

Volunteers received two vaccines meant to coach the body's immune system to recognise HIV, and another drug to "wake up" the reservoir cells hiding the virus, allowing it to be attacked by the body's own defences.

But trial participants who received these drugs had no different outcome to those on standard ART, said Sarah Fidler, a professor of HIV medicine at Imperial College London who took part in the research.

"Of course the overall effect wasn't what we would hope for, but it was definitive," she told journalists in the Dutch capital.

"All results move the knowledge forward even if they're somewhat disappointing."

For scientists, "cure" means weakening HIV to a point where it poses no harm to the infected person and cannot be transmitted to others—allowing people to stop treatment without any risk.

'Very difficult challenge'

"A cure remains a top scientific priority," said researcher Sharon Lewin of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

However, "what we've learnt, I think over the last decade: this is going to be a very difficult scientific challenge."

In another potential setback, a Thai study concluded that a type of "feminising hormone" used by transgender women appears to lower the concentration of a virus-repressing drug, tenofovir, in the blood.

This did not necessarily mean that hormone therapy renders the virus-repressing drug less effective, said Akarin Hiransuthikul of the Thai Red Cross AIDS Research Centre.

But further research is needed to unlock the potential repercussions.

There was some encouraging news too.

Updated findings in an ongoing study found zero infections among uninfected men in relationships with HIV-positive men who use virus-suppressing drugs.

Another study provided further evidence that "on-demand" use of antiretrovirals, pre- and post-sex, appears to work as a means of infection prevention.

And new data in the APPROACH vaccine study among nearly 400 HIV-negative adults, showed an immune response was still present 78 weeks after a fourth dose, though this does not yet constitute evidence that it works.

Explore further: First randomised trial of 'kick and kill' approach to HIV cure leaves puzzles to be solved

Related Stories

First randomised trial of 'kick and kill' approach to HIV cure leaves puzzles to be solved

July 24, 2018
Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known ...

Drug firm announces advance in quest for HIV cure

December 22, 2015
A Norwegian drug firm on Tuesday announced an advance in its quest for an HIV cure with a drug combination which seeks to force the virus out of its hiding place and kill it.

State-of-the-art HIV drug could curb HIV transmission, improve survival in India

April 30, 2018
An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 ...

Targeting HIV 'reservoir' could be first step to understanding how to cure the disease

December 1, 2015
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.

Risks to babies of mothers with HIV from three antiretroviral regimens appear to be low

April 25, 2018
The risk for preterm birth and early infant death is similar for three antiretroviral drug regimens taken by pregnant women with HIV according to a new study from Harvard T.H. Chan School of Public Health.

Alcoholism drug may help design HIV cure, study says

November 17, 2015
A treatment for alcoholism can reactivate dormant HIV, potentially allowing other drugs to spot and kill the virus hiding out in human immune cells, researchers said Tuesday.

Recommended for you

New HIV therapy reduces virus, boosts immunity in drug-resistant patients

August 15, 2018
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy ...

In choosing care, HIV patients in Zambia prefer kindness over convenience

August 15, 2018
As a healthcare patient, what would you sacrifice for a provider with a nice—rather than rude—attitude? For HIV patients in Zambia, the answer may surprise you.

Details of HIV-1 structure open door for potential therapies

August 9, 2018
New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Researchers uncover potential new drug targets in the fight against HIV

August 7, 2018
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that ...

Naltrexone helps HIV positive individuals reduce heavy alcohol use

August 7, 2018
Extended-release naltrexone—an injection that decreases heavy drinking in the general population when taken in conjunction with counseling—appears to help HIV-positive individuals reduce their number of heavy drinking ...

EU door opens for generic version of AIDS medicine Truvada

July 26, 2018
Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Rosemary1
not rated yet Aug 12, 2018
AN AMAZING REMEDY FOR HIV.
It's so unbelievable how wonderful herbs can be. when I first saw a post that said that a man have a perfect cure for HIV, I was like could this be real or some kind of scam but due to my eagerness to be cured I took the risk of contacting him, he gave me reasons to believe he is a real herbalist so I followed all his instructions and now all my test results shows HIV(-) negative , Dr. Zanbo have the most safe cure for herpes and other stubborn viruses.
contact him via his WhatsApp: +2347059420361 and email zanbospiritualhome@gmail.com trust me you will like this method, it's safe cheap and easy. do well by letting others know about this

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.